{"id":780,"date":"2021-08-24T20:51:02","date_gmt":"2021-08-24T20:51:02","guid":{"rendered":"https:\/\/chartwellpartners.com\/?p=780"},"modified":"2021-09-01T14:57:39","modified_gmt":"2021-09-01T14:57:39","slug":"xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2","status":"publish","type":"post","link":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/","title":{"rendered":"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer"},"content":{"rendered":"<p>Chartwell Partners recruited industry executive and neurologist, Chris Kenney, MD, as Chief Medical Officer for Xenon Pharmaceuticals, a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. Most recently, Dr. Kenney served as Chief Medical Officer for Cadent Therapeutics, a company focused on developing positive allosteric modulators for the treatment of cognitive, mood, and movement disorders. Cadent was acquired by Novartis in 2021. Previously, Dr. Kenney served in leadership positions with Acorda Therapeutics, Biotie Therapies, Novartis and Merck Serono.<\/p>\n<p>&nbsp;<\/p>\n<p>For more information on this appointment, please visit: <strong><a href=\"https:\/\/investor.xenon-pharma.com\/news-releases\/news-release-details\/xenon-pharmaceuticals-strengthens-leadership-team-appointment-dr\">https:\/\/investor.xenon-pharma.com\/news-releases\/news-release-details\/xenon-pharmaceuticals-strengthens-leadership-team-appointment-dr<\/a><\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chartwell Partners recruited industry executive and neurologist, Chris Kenney, MD, as Chief Medical Officer for Xenon Pharmaceuticals, a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. Most recently, Dr. Kenney served as Chief Medical Officer for Cadent Therapeutics, a company focused on developing positive allosteric&#8230;<\/p>\n","protected":false},"author":5,"featured_media":475,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_links_to":"","_links_to_target":""},"categories":[10],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer - Chartwell Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer - Chartwell Partners\" \/>\n<meta property=\"og:description\" content=\"Chartwell Partners recruited industry executive and neurologist, Chris Kenney, MD, as Chief Medical Officer for Xenon Pharmaceuticals, a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. Most recently, Dr. Kenney served as Chief Medical Officer for Cadent Therapeutics, a company focused on developing positive allosteric...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Chartwell Partners\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-24T20:51:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-01T14:57:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/06\/CWP-DefaultImage-Healthcare.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"846\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@chartwellus\" \/>\n<meta name=\"twitter:site\" content=\"@chartwellus\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/chartwellpartners.com\/#organization\",\"name\":\"Chartwell Partners\",\"url\":\"https:\/\/chartwellpartners.com\/\",\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/chartwell-partners\/\",\"https:\/\/twitter.com\/chartwellus\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/chartwellpartners.com\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/05\/logo.svg\",\"contentUrl\":\"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/05\/logo.svg\",\"caption\":\"Chartwell Partners\"},\"image\":{\"@id\":\"https:\/\/chartwellpartners.com\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/chartwellpartners.com\/#website\",\"url\":\"https:\/\/chartwellpartners.com\/\",\"name\":\"Chartwell Partners\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/chartwellpartners.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/chartwellpartners.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/06\/CWP-DefaultImage-Healthcare.jpeg\",\"contentUrl\":\"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/06\/CWP-DefaultImage-Healthcare.jpeg\",\"width\":1280,\"height\":846,\"caption\":\"CP Healthcare news post cover\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#webpage\",\"url\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/\",\"name\":\"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer - Chartwell Partners\",\"isPartOf\":{\"@id\":\"https:\/\/chartwellpartners.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#primaryimage\"},\"datePublished\":\"2021-08-24T20:51:02+00:00\",\"dateModified\":\"2021-09-01T14:57:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/chartwellpartners.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#webpage\"},\"author\":{\"@id\":\"https:\/\/chartwellpartners.com\/#\/schema\/person\/8ec60ae4e9acc2e16b16922de3e7d77d\"},\"headline\":\"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer\",\"datePublished\":\"2021-08-24T20:51:02+00:00\",\"dateModified\":\"2021-09-01T14:57:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#webpage\"},\"wordCount\":113,\"publisher\":{\"@id\":\"https:\/\/chartwellpartners.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/06\/CWP-DefaultImage-Healthcare.jpeg\",\"articleSection\":[\"HEALTHCARE\"],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/chartwellpartners.com\/#\/schema\/person\/8ec60ae4e9acc2e16b16922de3e7d77d\",\"name\":\"jblunk\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/chartwellpartners.com\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c1a825b298f1a058d60125284ac52cec?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c1a825b298f1a058d60125284ac52cec?s=96&d=mm&r=g\",\"caption\":\"jblunk\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer - Chartwell Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/","og_locale":"en_US","og_type":"article","og_title":"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer - Chartwell Partners","og_description":"Chartwell Partners recruited industry executive and neurologist, Chris Kenney, MD, as Chief Medical Officer for Xenon Pharmaceuticals, a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. Most recently, Dr. Kenney served as Chief Medical Officer for Cadent Therapeutics, a company focused on developing positive allosteric...","og_url":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/","og_site_name":"Chartwell Partners","article_published_time":"2021-08-24T20:51:02+00:00","article_modified_time":"2021-09-01T14:57:39+00:00","og_image":[{"width":1280,"height":846,"url":"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/06\/CWP-DefaultImage-Healthcare.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@chartwellus","twitter_site":"@chartwellus","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/chartwellpartners.com\/#organization","name":"Chartwell Partners","url":"https:\/\/chartwellpartners.com\/","sameAs":["https:\/\/www.linkedin.com\/company\/chartwell-partners\/","https:\/\/twitter.com\/chartwellus"],"logo":{"@type":"ImageObject","@id":"https:\/\/chartwellpartners.com\/#logo","inLanguage":"en-US","url":"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/05\/logo.svg","contentUrl":"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/05\/logo.svg","caption":"Chartwell Partners"},"image":{"@id":"https:\/\/chartwellpartners.com\/#logo"}},{"@type":"WebSite","@id":"https:\/\/chartwellpartners.com\/#website","url":"https:\/\/chartwellpartners.com\/","name":"Chartwell Partners","description":"","publisher":{"@id":"https:\/\/chartwellpartners.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chartwellpartners.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#primaryimage","inLanguage":"en-US","url":"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/06\/CWP-DefaultImage-Healthcare.jpeg","contentUrl":"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/06\/CWP-DefaultImage-Healthcare.jpeg","width":1280,"height":846,"caption":"CP Healthcare news post cover"},{"@type":"WebPage","@id":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#webpage","url":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/","name":"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer - Chartwell Partners","isPartOf":{"@id":"https:\/\/chartwellpartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#primaryimage"},"datePublished":"2021-08-24T20:51:02+00:00","dateModified":"2021-09-01T14:57:39+00:00","breadcrumb":{"@id":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/chartwellpartners.com\/"},{"@type":"ListItem","position":2,"name":"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer"}]},{"@type":"Article","@id":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#article","isPartOf":{"@id":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#webpage"},"author":{"@id":"https:\/\/chartwellpartners.com\/#\/schema\/person\/8ec60ae4e9acc2e16b16922de3e7d77d"},"headline":"Xenon Pharmaceuticals appoints Christopher Kenney, MD, as Chief Medical Officer","datePublished":"2021-08-24T20:51:02+00:00","dateModified":"2021-09-01T14:57:39+00:00","mainEntityOfPage":{"@id":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#webpage"},"wordCount":113,"publisher":{"@id":"https:\/\/chartwellpartners.com\/#organization"},"image":{"@id":"https:\/\/chartwellpartners.com\/healthcare\/xenon-pharmaceuticals-appoints-christopher-kenney-md-as-chief-medical-officer-2\/#primaryimage"},"thumbnailUrl":"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/06\/CWP-DefaultImage-Healthcare.jpeg","articleSection":["HEALTHCARE"],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/chartwellpartners.com\/#\/schema\/person\/8ec60ae4e9acc2e16b16922de3e7d77d","name":"jblunk","image":{"@type":"ImageObject","@id":"https:\/\/chartwellpartners.com\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/c1a825b298f1a058d60125284ac52cec?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1a825b298f1a058d60125284ac52cec?s=96&d=mm&r=g","caption":"jblunk"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/posts\/780"}],"collection":[{"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/comments?post=780"}],"version-history":[{"count":0,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/posts\/780\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/media\/475"}],"wp:attachment":[{"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/media?parent=780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/categories?post=780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/tags?post=780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}